Compared to Estimates, SurModics (SRDX) Q1 Earnings: A Look at Key Metrics

Core Insights - SurModics reported revenue of $29.92 million for the quarter ended December 2024, reflecting a year-over-year decline of 2.1% and an EPS of -$0.04 compared to $0.00 a year ago [1] - The reported revenue fell short of the Zacks Consensus Estimate of $33.45 million, resulting in a surprise of -10.55%, while the EPS exceeded expectations with a surprise of +50.00% against a consensus estimate of -$0.08 [1] Revenue Breakdown - Product sales amounted to $16.55 million, which is below the estimated $20.33 million, representing a year-over-year decline of 12.1% [4] - Revenue from research, development, and other sources was $2.74 million, slightly above the estimated $2.69 million, showing a year-over-year increase of 7.6% [4] - Royalties and license fees generated $10.63 million, surpassing the average estimate of $10.46 million, with a year-over-year growth of 15.9% [4] Stock Performance - Over the past month, SurModics shares have returned -9.7%, contrasting with the Zacks S&P 500 composite's increase of +1.2% [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), suggesting potential for outperformance in the near term [3]